Provided by Tiger Fintech (Singapore) Pte. Ltd.

Associated Capital

34.06
+0.24000.71%
Post-market: 34.060.00000.00%16:05 EDT
Volume:7.16K
Turnover:242.37K
Market Cap:720.45M
PE:16.40
High:34.41
Open:33.01
Low:33.00
Close:33.82
Loading ...

Cryptocurrency Exchange Company Hayvn Fined $12.45 Million by Abu Dhabi Regulatory Authority for Money Laundering Issues

Blockbeats
·
15 Apr

AC HOTEL BY MARRIOTT OTTAWA DOWNTOWN TO OPEN APRIL 24th, 2025

CNW Group
·
14 Apr

Air Canada Stock (TSE:AC) Slips, Adjusts Schedules to Meet New Realities

TIPRANKS
·
12 Apr

Arsenal, AC Milan and Newcastle United to play pre-season friendlies in Singapore

CNA
·
11 Apr

Associated Capital reports preliminary Q1 book value per share $42.42-$42.62

TIPRANKS
·
05 Apr

AC Reports Preliminary March 31 Book Value of $42.42 to $42.62 Per Share

GlobeNewswire
·
05 Apr

AC Immune Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Apr

AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease

GlobeNewswire
·
02 Apr

Nikko AM plans launch of Amova MSCI AC Asia ex Japan ex China Index ETF

The Edge Singapore
·
01 Apr

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025

GlobeNewswire
·
25 Mar

US Market Undiscovered Gems To Explore In March 2025

Simply Wall St.
·
21 Mar

Aircore Drilling to Commence at Balla Balla

GlobeNewswire
·
19 Mar

Enphase Energy Applauds New Rapid Shutdown Standard for Solar Installations in Brazil

GlobeNewswire
·
18 Mar

AC/DC Battery Metals Finalizes Sale of Copper Property to Grid Battery Metals

TIPRANKS
·
18 Mar

AC Immune: Promising Pipeline and Financial Stability Drive Buy Rating

TIPRANKS
·
17 Mar

AC Immune Price Target Maintained With a $16.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Mar

AC Immune SA Reports 2024 Financial Results and Strategic Advances

TIPRANKS
·
13 Mar

AC Immune reports FY24 EPS (51c), consensus (54c)

TIPRANKS
·
13 Mar

AC Immune FY24 EPS CHF(0.51) vs CHF(0.64) YoY; Contract Revenues CHF27.3M

Benzinga
·
13 Mar

Press Release: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update

Dow Jones
·
13 Mar